Navigation Links
New Educational Tool for Understanding UC Flares
Date:5/18/2009

MARIETTA, Ga., May 18 /PRNewswire/ -- Ulcerative colitis (UC) is a chronic, inflammatory bowel disease (IBD) affecting half a million people in the United States, yet many patients don't always understand how to recognize or treat the symptoms associated with the disease.

Ulcerative colitis is an inflammation of the lining of the rectum and colon. The disease is marked by unpredictable "flares" when the inflammation causing the disease state spikes, causing stomach pain and bloody diarrhea. Up to 80 percent of UC patients suffer from flares. This highlights the need for patient, physician, and caregiver information.(1)

To provide that information, an educational brochure titled, Managing Flares and other IBD Symptoms, is now available from the Crohn's and Colitis Foundation of America (CCFA), made possible by an educational grant from Alaven Pharmaceutical LLC, makers of the topical UC flare treatment, ROWASA Kit* (mesalamine rectal suspension enema).

The brochure further defines the symptoms of flare-ups for both Crohn's** disease and UC and includes information on diet and lifestyle, the treatment options for overall maintenance of the diseases and flares specifically, questions patients should ask their doctor when flares occur and a flare symptom tracker.(2)

"We've learned from patients and physicians that there is a need for outreach about what people living with inflammatory bowel diseases should know about flares," said Dave Riccio, Product Manager, Alaven Pharmaceutical. "Working with the CCFA to provide patients with another tool to fight against UC flares will help educate them on how to effectively manage their disease and treat unwanted flare symptoms when they strike."

Gastroenterologists interested in providing the flare brochure to UC patients may request copies at www.flarefighter.com.

The brochure will also be made available to CCFA patient chapters across the country and can be downloaded at www.ccfa.org or via www.RowasaKit.com. Patients experiencing flares and who would like additional support services may also visit the CCFA's community website at www.ccfacommunity.org.

ROWASA is indicated for the treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis, or proctitis.

Full Prescribing Information available: www.ROWASAKit.com.

*Wipe is optional and not a required part of treatment

**ROWASA is not indicated for the treatment of Crohn's Disease.

(1) Tindall WN, Boltri JM, Wihelm SM. Mild-to-Moderate Ulcerative Colitis: Your role in patient compliance and health care costs. JMCP. 2007;13(7): S1-S15.

(2) Managing Flares and Other IBD Symptoms. CCFA. April 2009.


'/>"/>
SOURCE Alaven Pharmaceutical LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Educational initiatives improve quality of care delivery
2. Ann Marie DeMatteo Joins CME LLC as Vice President of Educational Initiatives, Drives Innovative Programming Approaches
3. IOF launches educational slide kit to enhance understanding of FRAX
4. New Jersey IT Services Firm to Host Educational Luncheon Event, EMR & Information Technology for the Specialty Medical Practice
5. Medifecta Healthcare Training Launches Website with Educational Resources and Online Training for Caregivers
6. Womens International Pharmacy Offers Free Educational Information About Bioidentical Hormone Replacement Therapy
7. HIPAApedia.com Goes Live - The First Dedicated Educational Community Wiki Aimed at Healthcare Information Professionals Interested in HIPAA Regulatory Issues and Solutions.
8. April is National Autism Awareness Month: LoJack Hosts Educational Podcast Featuring Panel of Experts Addressing Autism Issues
9. CERTPOINT Systems Partners with Medcom Trainex, Inc. to Offer Extensive Library of Healthcare Courses -- Professionals in Healthcare sector to benefit from online educational courses
10. Spotlight Baby Provides Parents with Educational Programs and Eco-Friendly Products to Support Babies in Reaching Their Full Developmental Potentials
11. Edifecs Launches First of a Series of Edifecs5010(TM) Migration Educational Webinars Addressing 5010 Migration Challenges, Opportunities and Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest ... the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity drive ... rare and deadly chromosome abnormality. , After struggling since birth with several health ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International Association of ... of excellence for the field of eating disorders, announces the opening of early ... in Orlando, Florida at the Omni Resort at ChampionsGate. , The ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
Breaking Medicine Technology: